Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06203626 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ultra-Low Field (ULF) Point-of-Care (POC) MRI System for Brain Morphology and Pathology

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 82 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor Eligibility criteria expanded, about 11 words
    • Study description expanded, about 2 words
  2. Minor 22 versions Re-verified since Oct 30, 2024, no change to tracked fieldsv60-v81
  3. Minor Eligibility criteria revisedv59
  4. Minor 6 versions Re-verified since Apr 20, 2024, no change to tracked fieldsv53-v58
  5. Minor Eligibility criteria expanded, about 1 wordv52
Show 19 earlier versionsHide 19 earlier versions
  1. Minor 2 versions Re-verified since Mar 29, 2024, no change to tracked fieldsv50-v51
  2. Minor Start date changed from estimate of Apr 2, 2024 to Mar 26, 2024v49
  3. Minor Start date: Apr 1, 2024 to Apr 2, 2024v48
  4. Minor Start date: Mar 31, 2024 to Apr 1, 2024v47
  5. Minor Start date: Mar 28, 2024 to Mar 31, 2024v46
  6. Minor Start date: Mar 27, 2024 to Mar 28, 2024v45
  7. Minor Start date: Mar 26, 2024 to Mar 27, 2024v44
  8. Minor Start date: Mar 25, 2024 to Mar 26, 2024v43
  9. Minor Start date: Mar 22, 2024 to Mar 25, 2024v42
  10. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Mar 20, 2024 to Mar 22, 2024
    v41
  11. Minor Start date: Mar 18, 2024 to Mar 20, 2024v40
  12. Minor Start date: Mar 17, 2024 to Mar 18, 2024v39
  13. Minor Start date: Mar 14, 2024 to Mar 17, 2024v38
  14. Minor Start date: Mar 13, 2024 to Mar 14, 2024v37
  15. Minor Start date: Mar 12, 2024 to Mar 13, 2024v36
  16. Minor Start date: Mar 11, 2024 to Mar 12, 2024v35
  17. Minor Start date: Mar 10, 2024 to Mar 11, 2024v34
  18. Minor Start date: Mar 7, 2024 to Mar 10, 2024v33
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Magnetic resonance imaging (MRI) is a tool for getting pictures of the tissues and organs inside the body. MRI can help diagnose many injuries and diseases. But not all patients are equally likely to receive MRIs. Factors such as race or ethnicity, distance to imaging centers, mobility, and a lower income can limit some people s access to MRIs. A new ultra-low field (ULF) type of MRI, which can be used on a vehicle, may help take imaging scans to more people. But researchers need to know that UFL-MRI works just as well as standard MRIs. Objective: To learn whether UFL-MRI is as good as standard MRI at detecting neurological disorders. Eligibility: People aged 3 years or older who have or show symptoms of neurological disease (such as stroke, cancer, or epilepsy). Healthy adults are also needed. Design: Participants will have 1 or 2 study visits. Adult participants will have a physical exam. They will receive two MRI exams: * Standard MRI. They will lie still on a narrow bed that will move into a large tube. They will wear earplugs to muffle the sounds. * ULF-MRI. They will lie on a stretcher, and only their head will be inside a smaller tube. The noises will be quieter. They will wear earplugs to muffle the sounds. Some adults may receive a contrast agent given through a small tube attached to a needle in the arm. The contrast agent helps the researchers see differences in the body more clearly. This may be done during 1 or both MRIs. Children will have only 1 ULF-MRI. Some participants may be invited to have additional visits for up to 6 months.
Trial Details
NCT Number NCT06203626
Lead Sponsor National Institute of Neurological Disorders and Stroke (NINDS)
Conditions
(from sponsor)
Nervous System Diseases (C10 Unique ID D009422)
Related terms Nervous System Diseases
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov